U.S. FDA removes COVID test requirements for Pfizer, Merck pills
Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021. FDA said the patients should have a current diagnosis of mild-to-moderate COVID infection. Individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result.
Published 4 months ago
Time & Location
Sources are mostly out of (0)
Bias Distribution
50% of the sources are Center, 50% of the sources lean Right
C 50%
R 50%
See less detail
